120467-36-9

Upstream product

• 2150-44-9 1-carbomethoxy-3,5-dihydroxybenzene 
• 120467-35-8 3,5-Bis-(2-methoxy-ethoxymethoxy)-benzoic acid methyl ester 

Downstream Products

• 120467-34-7 2-[(E)-3-[3,5-Bis-(2-methoxy-ethoxymethoxy)-phenyl]-prop-2-en-(E)-ylidene]-malonic acid monomethyl ester 
• 120467-37-0 3,5-Bis-(2-methoxy-ethoxymethoxy)-benzaldehyde 
• 288849-96-7 1-bromomethyl-3,5-bis-(2-methoxy-ethoxymethoxy)-benzene 
• 120467-43-8 (2E,4E)-5-[3,5-Bis-(2-methoxy-ethoxymethoxy)-phenyl]-penta-2,4-dienoic acid methyl ester 
• 120467-32-5 (2E,4E)-methyl 5-(3,5-dihydroxyphenyl)penta-2,4-dienoate 
• 288850-01-1 C₃₇H₅₁BrO₁₄ 
• 288850-00-0 {3,5-bis-[3,5-bis-(2-methoxy-ethoxymethoxy)-benzyloxy]-phenyl}-methanol 
• 288849-97-8 C₃₁H₃₅N₃O₇ 

Relevant academic research and scientific papers

Synthesis and characterisation of water-soluble poly(aryl ether) dendrimers for encapsulation of biomimetic active site analogues

Synthetic strategies to incorporate active site analogues of metalloenzymes at the core of water-soluble dendritic structures are explored. Synthesis of water-soluble aryl ether dendrimers containing tripyridyl metal-binding sites is successful when a con

Synthesis of Cannabinoids Carrying ω-Carboxy Substituents: The Cannabidiols, Cannabinol and Δ1- and Δ6-Tetrahydrocannabinols of this Series

A convenient synthesis of methyl 5-(3,5-dihydroxyphenyl)pentanoate adaptable for isotopic side-chain labelling is reported.Using acid-catalysed terpenylations involving (1S,4R)-(+)-trans-p-menthadienol, conditions for making (3R,4R)-o- and p-cannabidiols,